In Hawaii, two competing clinical laboratory companies have joined forces to save a medical technologist (MT) training program from closure. Together, Clinical Laboratories of Hawaii, LLP (CLH–owned by Sonic Healthcare), and Diagnostic Laboratory Services, Inc. (DLS), contributed more than $100,000 to the John A. Burns School of Medicine (JABSOM) at the University of Hawaii at
Tag: pathology images
CEO SUMMARY: Laboratory medicine is about to find itself between the two jaws of a powerful vise. One jaw is pending major legislative overhaul of the entire healthcare system, along with dwindling reimbursement as Medicare and Medicaid runs out of money. The other jaw is personalized medicine, companion diagnostics, and expensive molecular testing. As these
CEO Summary: Pathologists at the Hospital of the University of Pennsylvania are using a new system that combines image analysis software and algorithms to evaluate images containing numerous stains and biomarkers. Pathologists teach the system to identify tumor cells and distinguish them from non-tumor cells. Now used for research purposes, this sophisticated digital pathology system
Editor’s Note: Guest writer Martin Perry attended the FDA’s advisory panel on digital pathology conducted earlier this month. He is CEO of The Perry Group and has extensive experience in imaging and healthcare. He offers his insights from the FDA proceedings on digital pathology imaging.
DIGITAL PATHOLOGY CONTINUES to gain acceptance at a steady but measured
CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase after seeing a demonstration. Pathologists at Scripps are preparing for a future in which digital imaging
LAB PROFESSIONALS WHO HAVE worked in regions like Africa know that the infrastructure in developing countries is limited or nonexistent. This makes it challenging to provide clinical laboratory testing services that are up to the standards common in developed countries.
For example, it can be difficult for a laboratory in a developing country to report lab
Effective May, 1, 2009, Laboratory Corporation of America will no longer be a contract provider for Regence BlueShield, head-quartered in Seattle, Washington. Regence notified physicians that it was ending its relationship with LabCorp “as a result of rising costs of care provided in our markets and LabCorp’s refusal to accept market level reimbursement. …Regence is committed to
CEO SUMMARY: Anatomic pathology groups across the nation must develop effective strategies to address challenges in pricing, intensifying competition, and expensive new technologies. That’s the assertion of three pathology practice administrators who have organized a boot camp in Dallas next month specifically to train other practice administrators and managers. This event will provide administrators from
CEO SUMMARY: If BioImagene’s CEO is to be believed, the company is ready to deliver a digital pathology system that is robust and affordable, even in settings with just two or three pathologists. One key to the BioImagene strategy is “per scan” pricing that avoids the need for upfront capital to acquire its system. Confident
CEO SUMMARY: Digital pathology imaging systems are finding uses in all phases of drug discovery (discovery, pre-clinical, clinical trials), as well as education, research, and clinical. One hurdle to widespread adoption of fully digitized, whole-slide pathology imaging systems is FDA clearance that allows the use of this technology for primary diagnosis. Executives at two of